Ultrasonic Scalpel Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Ultrasonic Scalpel Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Ultrasonic Scalpel Market is expected to grow at a CAGR of 6.5% during the forecast period (2022 - 2027).

The COVID-19 pandemic has had ramifications on various surgical procedures, including minimally invasive procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases because of a reduction in hospital visits, which impacted the studied market. For instance, according to the research study published in August 2020, titled “Overall Impact of the COVID-19 Pandemic on Interventional Radiology Services: A Canadian Perspective”, the COVID-19 pandemic had negatively impacted the interventional radiology services in Canada, especially for elective cases, and as per the study, about 49.3% of the respondents reported that there was an overall decline in interventional radiology services in the country. Thus, COVID-19 has a significant impact on market growth. However, with the ongoing vaccinations and decreasing cases of COVID-19, the studied market is expected to regain its full potential over the forecast period.

Certain factors that are propelling the market growth are the rising burden of chronic diseases and increased demand for minimally invasive procedures.

The increasing prevalence of chronic diseases is the key factor driving the growth of the ultrasonic scalpel market. For instance, as per Cancer Australia, in 2021, it was estimated that 20,030 new cases of breast cancer were diagnosed in Australia (164 males and 19,866 females). As per the same source, in 2021, it is estimated that a person has a 1 in 15 (or 6.7%) risk of being diagnosed with breast cancer by the age of 85 (1 in 8 or 13% for females and 1 in 829 or 0.12% for males). Also, as per the British Heart Foundation England Factsheet, published in January 2022, about 6.4 million people are living with cardiovascular diseases in England. Also, as per the British Heart Foundation 2020 fact sheet, around 7.4 million people are living with heart and circulatory diseases in the United Kingdom. The high incidence of heart diseases is expected to increase cardiac surgeries which are further anticipated to increase the demand for ultrasonic scalpels, thereby fueling the market growth. Similarly, according to an article published by Clinical Liver Disease, in May 2021, titled “Global Epidemiology of Chronic Liver Disease”, Cirrhosis is a leading cause of mortality and morbidity across the world. In addition, in 2020, the number of people with HBV infection was projected to reach 3.63% (279,9 million), with as few as 36.7 million cases of infection having been identified. Thus, the increasing burden of liver diseases among the population is expected to increase the demand for liver surgeries, thereby propelling market growth.

In addition, the demand for minimally invasive procedures is increasing rapidly due to its several advantages over conventional procedures such as less post-operative pain, fewer major operative, and postoperative complications, faster recovery times, less scarring, less stress on the immune system, and smaller incisions. These benefits of minimally invasive procedures reduce the overall hospital and the cost of the treatment, due to which this procedure is increasingly adopted, which is expected to increase the market growth over the forecast period.

However, the stringent regulation and the high cost associated with the procedure are expected to impede the market growth over the forecast period.

Key Market TrendsGynecologic Cancer Segment is Expected to Show Better Growth in the Forecast Years

The gynecological cancer segment is expected to witness significant growth in the ultrasonic scalpel market over the forecast period owing to the factors such as the increasing burden of gynecological cancers, and the increasing adoption of ultrasonic scalpel devices for treatment.

The rising prevalence of gynecological cancer is the key factor driving the market growth. For instance, as per the National Center for Biotechnology Information, 2021, cervical cancer is the fourth most common gynecologic cancer and the second leading cause of death in women. Additionally, according to World Health Organization, in 2022, Cervical cancer is the world's fourth most common cancer in women. In addition, as per the same source, in 2020, low- and middle-income countries accounted for approximately 90% of new cases and deaths worldwide. Also, as per GLOBOCAN 2020, 18.3% of new cervical cancer cases were reported in India in 2020 and cervical cancer accounted for 9.4% of all cancers. Similarly, according to World Health Organization International Agency for Research on Cancer (IARC) projections, it is estimated that 124,000 new cases of cervical cancer and 77,000 deaths occurred in 2020 in India. Thus, the increasing burden of gynecological cancer among the population is expected to increase the demand for ultrasonic scalpels in tissue identification during surgery, thereby propelling market growth.

In addition, according to an article published by the American Chemical Society (ACS) Publications, in March 2021, titled ‘Validation of Ultrasonic Harmonic Scalpel for Real-Time Tissue Identification Using Rapid Evaporative Ionization Mass Spectrometry’, the ultrasonic harmonic surgical scalpel is the next-generation energy device used for dissection during minimally invasive surgery for colorectal cancer. In addition, based primarily on fatty acid and glycolipid ion abundances, the Harmonic surgical scalpel can distinguish the metabolic profiles of abdominal organs with great accuracy. This is expected to propel the market growth over the forecast period.

Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.

North America holds the Largest Share in the Ultrasonic Scalpel Market

North America is expected to hold a significant market share in the ultrasonic scalpel market owing to the increasing prevalence of chronic diseases, rising healthcare spending, and technological advancement in the region.

The rising burden of chronic diseases such as cardiovascular diseases, cancers, and others is expected to increase market growth. For instance, according to the American Cancer Society, in 2022, an estimated 268,490 new prostate cancer cases were identified, and 34,500 deaths were reported in the United States. Also, according to the statistics published by the American Society of Clinical Oncology, in May 2022, an estimated 151,030 adults in the United States will be diagnosed with colorectal cancer, in 2022. In addition, an estimated 1,880,725 people were diagnosed with colorectal cancer in 2020. Similarly, according to National Cancer Institute, in 2022, it was found that an estimated 233,565 women were living with ovarian cancer in the United States.

In addition, according to 2022 statistics published by American Heart Association, the prevalence rate of heart failure in the United States is 6 million, which is 1.8% of the total population, and the prevalence rate of heart failure in Canada is between 1.5% to 1.9% in 2021. Also, the research study published by Cardiovascular Diabetology, in June 2020, titled “Cardiovascular and diabetes burden attributable to physical inactivity in Mexico,” reported that the 31% increase in physical inactivity increased the number of cases of type 2 diabetes (27,100), coronary heart disease (10,300), stroke (2200), myocardial infarction (1500), stroke deaths (400), and coronary heart disease deaths (350). Thus, changing lifestyles leading to physical inactivity can further increase the risk of heart disease which is expected to increase the demand for surgeries that uses ultrasonic scalpel for differentiating and accurately examining the tissues, thereby fueling the market growth.

In addition, the rising healthcare spending in the region is expected to increase the company’s activities in developing innovative and technologically advanced products, which is expected to propel market growth over the forecast period. For instance, according to the Organization for Economic Co-operation and Development (OECD), in June 2022, United States healthcare spending, in 2021 was 17.8% of the total GDP of the country. Additionally, as per the data published by the Centers for Medicare & Medicaid Services, in March 2022, titled “CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures”, it has been observed that the annual growth in national health spending is expected to average 5.1% over 2021-2030. In addition, the National Health Spending in 2020 was USD 4.1 trillion and it is projected to reach USD 6.8 trillion by 2030.

Moreover, the growing company’s focus on research and development activities and rising product approvals in the region are expected to boost the market growth over the forecast period. For instance, in December 2021, the United States Food and Drug Administration granted clearance to Bioventus’s neXus BoneScalpel Access handpiece. The BoneScalpel Access handpiece is powered by the neXus Ultrasonic Surgical Aspirator System, a next-generation integrated ultrasonic surgical platform driven by a proprietary digital algorithm that results in more power, versatility, and control. This launch provides surgeons with a new option for confined spaces during minimally invasive surgery enabling safe and powerful bone removal with maximum visualization.

Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.

Competitive Landscape

The market studied is moderately competitive, and there are several global companies that have been operating in the market studied. The major players in the ultrasonic scalpel market are Axon Medical Solutions Pvt. Ltd, BOWA Medical UK, Johnson & Johnson, Medtronic PLC, Misonix, Olympus Corporation, Stryker Corporation, and Wuhan BBT Medical Tech. Co. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.